Cultrera, R. 2024. Place in therapy of dalbavancin to treat Gram-positive infections in antimicrobial resistance era: an overview. Global and Regional Health Technology Assessment. 11, Suppl. 2 (Jul. 2024), 1–4. DOI:https://doi.org/10.33393/grhta.2024.3108.